Influence of a genetic signature on therapeutic effects of clozapine in schizophrenia subjects from South China

ITME 2011 - Proceedings: 2011 IEEE International Symposium on IT in Medicine and Education

Volumn 1, Issue , 2011, Pages 501-504

  Gong, Daoyuan ^a   Li, Ziping ^a   Li, Bo ^a   Gan, Chunbao ^a   Wang, Xiaojuan ^a  

^a FOSHAN UNIVERSITY   (China)

Author keywords

5 HT; Clozapine; COMT; DR; Schizophrenia; SNP

Indexed keywords

5-HT; CLOZAPINE; COMT; DR; SCHIZOPHRENIA; SNP;

DISEASES; GENES;

PATIENT TREATMENT;

EID: 84863069569     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ITiME.2011.6130885     Document Type: Conference Paper

References (15)

1. Landolt HP, Wehrle R.Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood[J]?Eur J Neurosci, 2009, 29(9):1795-809.
2. Alfimova MV, Monakhov MV, Abramova LI, et al. Polymorphism of serotonin receptor genes (5-HTR2A) and Dysbindin (DTNBP1) and individual components of short-term verbal memory processes in Schizophrenia[J].Neurosci Behav Physiol, 2010, 40(8):934-40.
3. Tee SF, Chow TJ, Tang PY, et al. Linkage of schizophrenia with TPH2 and 5-HTR2A gene polymorphisms in the Malay population[J].Genet Mol Res, 201 0, 9(3): 1274-8.
4. Arranz M, Collier D, Sodhi M, et a1. Association between c1ozapine response and allelic variation m 5-HT2A receptor gene[J].Lancet, 1995, 346:281-2.
5. Dalila Benmessaoud, Nora Hamdani, Claudette Boni, et al. Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A
6. Zhao AL, Zhao JP, Liu HD, et al.Association between 5-HT 2A gene T102C polymorphisms and individual c1ozapineresponse[J].The Chinese Journal of Clinical Pharmacology, 2004, 4(22):30-3.
7. Di Giannantonio M, Di Iorio G, Guglielmo R, et al. Major depressive disorder, anhedonia and agomelatine: an open-label study[J].J Biol Regul Homeost Agents, 2011, 25(1): 109-14.
8. Liu YJ. Association of 5-HT2Cc receptors genes polymorphism and medication effects in schizophrenic Patients:[Master Thesis].Central South University , Psychiatry and mental health, 2008.
9. Novak G, LeBlanc M, Zai C, et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia[J].Ann Hum Genet, 2010, 74(4):291-8.
10. Malhotra A K, Murphy G M Jr, Kennedy J L, et al. Pharmacogenetics of sychotropic drug response[J].Am J Psychiatry, 2004, 161 :780-96.
11. Hwang R, Shinkai T, De Luca V, et al.Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response[J].J Psychopharrnacol, 2007, 21(7):718-27.
12. Rudi Hwang, Takahiro Shinkai, Vincenzo De Luca, et al.Association study of four dopamine DI receptor gene polymorphisms and clozapine treatment response[J].Journal of Psychopharrnacology, 2007, 21 (7):718-727.
13. Rudi Hwang, Takahiro Shinkai, Vincenzo De Luca.Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations[J]. Psychopharmacology, 2005, l81: 179-87.
14. Dong JY, Gao SG, Hu ZY, et al.Research progress on COMT gene polymorphismsand schizophrenia[J].The Chinese Journal of Clinical Pharrnacology, 2010, 26(8):630-3.
15. Woodward ND, Jayathilake K, Meltzer HY.COMT va1l08/l58met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia[J].SchizophrRes, 2007, 90(1-3):86-96.